CVRR

Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
木曜日, 2月 29, 2024

DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter and year ended December 31, 2023 and provided an update on the Company’s operations.

Key Points: 
  • Net product revenue for the three months ended December 31, 2023 was $70.6 million, compared to $89.5 million in the corresponding period of 2022, a decrease of 21%.
  • USA net product revenue was $64.9 million for the three months ended December 31, 2023 compared to $88.0 million in the corresponding period of 2022.
  • Cost of goods sold for the three months ended December 31, 2023 was $29.6 million, compared to $26.6 million in the corresponding period of 2022.
  • As of December 31, 2023, Amarin reported aggregate cash and investments of $321 million.

Amarin Reports Third Quarter 2023 Financial Results

Retrieved on: 
水曜日, 11月 1, 2023

-- Company to Host Conference Call Today at 8:00 a.m. ET --

Key Points: 
  • ET --
    DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced financial results for the quarter ended September 30, 2023 and provided an update on company operations.
  • “As we focus on demonstrating results that will drive shareholder value, there are reasons to be optimistic about the future of Amarin,” said Patrick Holt, President & CEO of Amarin.
  • U.S. product net revenue was $62.4 million in the third quarter of 2023, a decline of $2.2 million versus the second quarter of 2023, a decrease of 3% sequentially.
  • The company has provided these non-GAAP financial measures in addition to GAAP financial results because it believes that these non-GAAP adjusted financial measures provide investors with a better understanding of the company’s historical results from its core business operations.

Amarin Partner EddingPharm Receives Regulatory Approval for Vascepa® (Icosapent Ethyl) in Mainland China

Retrieved on: 
木曜日, 6月 1, 2023

DUBLIN, Ireland and BRIDGEWATER, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that its commercial partner in China, EddingPharm (EDDING), has received regulatory approval for VASCEPA® (icosapent ethyl) from China’s National Medical Products Administration (NMPA). NMPA granted approval for VASCEPA as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL).

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., June 01, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that its commercial partner in China, EddingPharm (EDDING), has received regulatory approval for VASCEPA® (icosapent ethyl) from China’s National Medical Products Administration (NMPA).
  • NMPA granted approval for VASCEPA as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia (≥500 mg/dL).
  • Following regulatory approval, EDDING is now focusing on National Reimbursement Drug Listing (NRDL) and preparing for commercial launch in China, expected by year-end, as well as on advancing regulatory submission and review for an additional indication in cardiovascular risk reduction (CVRR).
  • Following the NMPA approval for this indication, Amarin is now entitled to receive a regulatory milestone payment of $5 million.

Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVR Refining, LP (CVRR)

Retrieved on: 
金曜日, 4月 17, 2020

Investors suffering losses on their CVRR investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .

Key Points: 
  • Investors suffering losses on their CVRR investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .
  • Under the Call Right, the General Partner had the right to acquire all remaining CVRR units for a specified price.
  • On August 1, 2018, the Company stated that there were no current plans to exercise the call right.
  • On October 24, 2018, CVRR released its third quarter 2018 financial results, a significant increase over the prior year results.

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against of CVR Refining, LP (CVRR)

Retrieved on: 
水曜日, 4月 15, 2020

Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming June 5, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who sold CVR Refining, LP ("CVRR" or the Company") ( CVRR ) common units between July 30, 2018 through January 28, 2019, inclusive (the Class Period).

Key Points: 
  • Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming June 5, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who sold CVR Refining, LP ("CVRR" or the Company") ( CVRR ) common units between July 30, 2018 through January 28, 2019, inclusive (the Class Period).
  • Under the Call Right, the General Partner had the right to acquire all remaining CVRR units for a specified price.
  • On August 1, 2018, the Company stated that there were no current plans to exercise the call right.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

CVRR INVESTOR UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies CVR Refining, LP Shareholders of Class Action and Encourages Investors to Contact the Firm

Retrieved on: 
月曜日, 4月 13, 2020

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CVR Refining, LP ("CVRR") on behalf of shareholders who purchased CVRR between July 30, 2018 and January 28, 2019, inclusive (the "Class Period").

Key Points: 
  • Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CVR Refining, LP ("CVRR") on behalf of shareholders who purchased CVRR between July 30, 2018 and January 28, 2019, inclusive (the "Class Period").
  • Such investors are encouraged to join this case by visiting the firms site: www.bgandg.com/cvrr .
  • This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.
  • or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484.

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of CVR Refining, LP (CVRR) Investors

Retrieved on: 
木曜日, 4月 9, 2020

Glancy Prongay & Murray LLP (GPM), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors who sold CVR Refining, LP ("CVRR" or the Company") ( CVRR ) common units between July 30, 2018 through January 28, 2019, inclusive (the Class Period).

Key Points: 
  • Glancy Prongay & Murray LLP (GPM), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of investors who sold CVR Refining, LP ("CVRR" or the Company") ( CVRR ) common units between July 30, 2018 through January 28, 2019, inclusive (the Class Period).
  • CVRR investors have until June 5, 2020 to file a lead plaintiff motion.
  • Under the Call Right, the General Partner had the right to acquire all remaining CVRR units for a specified price.
  • On October 24, 2018, CVRR released its third quarter 2018 financial results, a significant increase over the prior year results.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf CVR Refining, LP (CVRR) Investors

Retrieved on: 
木曜日, 4月 9, 2020

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who sold CVR Refining, LP ("CVRR" or the Company") ( CVRR ) common units between July 30, 2018 through January 28, 2019, inclusive (the Class Period).

Key Points: 
  • Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who sold CVR Refining, LP ("CVRR" or the Company") ( CVRR ) common units between July 30, 2018 through January 28, 2019, inclusive (the Class Period).
  • Investors suffering losses on their CVRR investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected] .
  • Under the Call Right, the General Partner had the right to acquire all remaining CVRR units for a specified price.
  • On October 24, 2018, CVRR released its third quarter 2018 financial results, a significant increase over the prior year results.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of CVR Refining, LP (CVRR) on Behalf of Investors

Retrieved on: 
木曜日, 4月 9, 2020

Under the Call Right, the General Partner had the right to acquire all remaining CVRR units for a specified price.

Key Points: 
  • Under the Call Right, the General Partner had the right to acquire all remaining CVRR units for a specified price.
  • On August 1, 2018, the Company stated that there were no current plans to exercise the call right.
  • On October 24, 2018, CVRR released its third quarter 2018 financial results, a significant increase over the prior year results.
  • Glancy Prongay & Murray LLP is a premier law firm representing investors and consumers in securities litigation and other complex class action litigation.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CVR Refining, LP (CVRR) on Behalf of Investors

Retrieved on: 
木曜日, 4月 9, 2020

Law Offices of Howard G. Smith announces an investigation on behalf CVR Refining, LP ("CVRR" or the Company") ( CVRR ) investors concerning the Company and its officers possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf CVR Refining, LP ("CVRR" or the Company") ( CVRR ) investors concerning the Company and its officers possible violations of federal securities laws.
  • Under the Call Right, the General Partner had the right to acquire all remaining CVRR units for a specified price.
  • On August 1, 2018, the Company stated that there were no current plans to exercise the call right.
  • On October 24, 2018, CVRR released its third quarter 2018 financial results, a significant increase over the prior year results.